When pathologists discuss parafibromin, it is typically in the context of diagnosing an atypical parathyroid tumor or parathyroid carcinoma, as these conditions are more frequently associated with CDC73 gene mutations compared to parathyroid adenomas [2, 3]. Here, CDC73 is linked to parathyroid gland adenoma.